EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY-NC-ND 4.0

Unmet Need and Treatment Expectations of Previously Treated Patients with Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer: A Qualitative Interview Study

Jyoti D Patel, Jie Meng, Aura Cecilia Jimenez-Moreno, Friso Coerts, Meredith Venerus, Sarah Park, Mohammed Inaam-Ul Haq, Boris Gorsh, Tommi Tervonen

Clinical Lung Cancer · 2026

DOI: 10.1016/j.cllc.2026.02.003 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Clinical Lung Cancer, 2026. Verfasst von Jyoti D Patel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, IL. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tyrosine Kinase Inhibitors, Antineoplastic Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Daiichi Sankyo Europe GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Treatment effectiveness remains limited for patients with previously treated epidermal growth factor receptor (EGFR)-mutated advanced nonsmall cell lung cancer (NSCLC). Understanding patient unmet needs and treatment expectations can inform drug development decisions. METHODS: Qualitative interviews were conducted with n = 37 patients from the US, UK, Germany, Spain, and Italy who had locally advanced or metastatic EGFR-mutated NSCLC and had suffered from progressive disease while on osimertinib. Interview transcripts were analyzed following the content analysis technique. Participants also completed a questionnaire that included the EQ-5D-5 L and NSCLC-symptoms assessment questionnaire. RESULTS: All participants reported experiencing at least one respiratory symptom, such as fatigue or tiredness, with 97% reporting both. The most common impact on the participants' daily life activities was the incapacity to do any physical exertion (54%). All participants reported at least one emotional impact, most commonly mentioned as feeling scared/frightened or anxious/worried (62%), followed by feeling upset, unhappy, or depressed (57%). Improving quality of life was the most desired treatment outcome (76%), followed by slowing disease progression and remission (71% each). Most participants (81%) were willing to consider a new treatment despite the potential for side effects. From EQ-5D-5 L domains, "anxiety/depression" had the highest impact on participants' lives. The most severe symptoms based on NSCLC-symptoms assessment questionnaire were fatigue, pain, and dyspnea. CONCLUSION: Patients with previously treated EGFR-mutated advanced NSCLC have significant symptom burden and emotional impacts of the disease. These patients would realistically expect a treatment that could improve their quality of life and delay the progression of their disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsTyrosine Kinase InhibitorsAntineoplastic AgentsAcrylamidesDrug DevelopmentErbB ReceptorsMutationQualitative ResearchAniline CompoundsIndolesPyrimidinesInterviews as TopicNeoplasm StagingSurveys and QuestionnairesSymptom BurdenTreatment OutcomeActivities of Daily LivingQuality of LifeDisease ProgressionHumansMaleFemaleMiddle Aged

Stichwörter der Autor:innen

Disease burdenEGFR-mutatedInterviewsLung cancerMetastaticTreatment expectations

Substanzen

AcrylamidesEGFR protein, humanErbB ReceptorsosimertinibTyrosine Kinase InhibitorsAniline CompoundsIndolesPyrimidinesAntineoplastic Agents

Autor:innen und Institutionen

  • Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Daiichi Sankyo Europe, Munich, Germany.
  • Kielo Research, York, UK. Electronic address: cecilia.jimenez-moreno@kieloresearch.com.
  • Daiichi Sankyo, Basking Ridge, NJ.
  • Kielo Research, Zug, Switzerland.

Förderung

  • Daiichi Sankyo Europe GmbH

Zitieren

APA

Patel, J. D., Meng, J., Jimenez-Moreno, A. C., Coerts, F., Venerus, M., Park, S., Inaam-Ul Haq, M., Gorsh, B., & Tervonen, T. (2026). Unmet Need and Treatment Expectations of Previously Treated Patients with Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer: A Qualitative Interview Study. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2026.02.003

Vancouver

Patel JD, Meng J, Jimenez-Moreno AC, Coerts F, Venerus M, Park S, et al. Unmet Need and Treatment Expectations of Previously Treated Patients with Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer: A Qualitative Interview Study. Clinical Lung Cancer. 2026. doi:10.1016/j.cllc.2026.02.003

BibTeX
@article{Patel2026,
  author = {Patel, Jyoti D and Meng, Jie and Jimenez-Moreno, Aura Cecilia and Coerts, Friso and Venerus, Meredith and Park, Sarah and Inaam-Ul Haq, Mohammed and Gorsh, Boris and Tervonen, Tommi},
  title = {Unmet Need and Treatment Expectations of Previously Treated Patients with Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer: A Qualitative Interview Study},
  journal = {Clinical Lung Cancer},
  year = {2026},
  doi = {10.1016/j.cllc.2026.02.003}
}
Kostenlos starten →